Compounds > sr 27897
Page last updated: 2024-09-03

sr 27897 and sr 146131

sr 27897 has been researched along with sr 146131 in 5 studies

Compound Research Comparison

Studies
(sr 27897)		Trials
(sr 27897)		Recent Studies (post-2010)
(sr 27897)		Studies
(sr 146131)		Trials
(sr 146131)		Recent Studies (post-2010) (sr 146131)
483161201

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bachy, A; Bignon, E; Boigegrain, R; Brodin, R; Cottineau, M; Gully, D; Herbert, JM; Keane, P; Labie, C; Le Fur, G; Maffrand, JP; Molimard, JC; Olliero, D; Oury-Donat, F; Pascal, M; Petereau, C; Prabonnaud, V; Rockstroh, MP; Schaeffer, P; Servant, O; Soubrié, P; Thurneyssen, O1
Carillon, C; Delpech, B; Ferrara, P; Gouldson, P; Le Fur, G; Legoux, P; Shire, D2
Carillon, C; Dumont, X; Ferrara, P; Gouldson, P; Le Fur, G; Legoux, P; Shire, D1
Archer-Lahlou, E; Dufresne, M; Escrieut, C; Fourmy, D; Maigret, B; Moroder, L; Pradayrol, L; Seva, C; Tikhonova, I1

Other Studies

5 other study(ies) available for sr 27897 and sr 146131

ArticleYear
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:2

    Topics: 3T3 Cells; Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; CHO Cells; Cricetinae; Devazepide; DNA-Binding Proteins; Early Growth Response Protein 1; Genes, Immediate-Early; Hormone Antagonists; Humans; Immediate-Early Proteins; Indoleacetic Acids; Indoles; Inosine Monophosphate; Mice; Neuroblastoma; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Recombinant Proteins; Sincalide; Thiazoles; Transcription Factors; Tumor Cells, Cultured

1999
Contrasting roles of leu(356) in the human CCK(1) receptor for antagonist SR 27897 and agonist SR 146131 binding.
    European journal of pharmacology, 1999, Nov-03, Volume: 383, Issue:3

    Topics: Animals; Binding Sites; COS Cells; Hormone Antagonists; Humans; Indoleacetic Acids; Indoles; Leucine; Point Mutation; Receptors, Cholecystokinin; Sincalide; Thiazoles

1999
Essential role of extracellular charged residues of the human CCK(1) receptor for interactions with SR 146131, SR 27897 and CCK-8S.
    European journal of pharmacology, 2000, Feb-18, Volume: 389, Issue:2-3

    Topics: Amino Acid Sequence; Animals; COS Cells; Dose-Response Relationship, Drug; Humans; Indoleacetic Acids; Indoles; Inositol Phosphates; Molecular Sequence Data; Mutation; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; Sincalide; Structure-Activity Relationship; Thiazoles

2000
The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK(1) receptor.
    European journal of pharmacology, 2000, Jul-21, Volume: 400, Issue:2-3

    Topics: Amino Acid Sequence; Animals; Binding Sites; Binding, Competitive; COS Cells; Hormone Antagonists; Humans; Indoleacetic Acids; Indoles; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Point Mutation; Protein Conformation; Protein Structure, Tertiary; Receptors, Cholecystokinin; Thiazoles

2000
Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptor.
    Journal of medicinal chemistry, 2005, Jan-13, Volume: 48, Issue:1

    Topics: Amino Acid Motifs; Amino Acid Sequence; Animals; Benzodiazepinones; Binding Sites; Chlorocebus aethiops; Cholecystokinin; COS Cells; Devazepide; Humans; Indoleacetic Acids; Indoles; Ligands; Lipid Metabolism; Lipids; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Phenylurea Compounds; Protein Conformation; Receptor, Cholecystokinin A; Rhodopsin; Sequence Homology, Amino Acid; Thiazoles

2005